McKesson Ventures, LLC - 13 Dec 2022 Form 4 Insider Report for Augmedix, Inc.

Reporting relationship: Former 10% Owner
Issuer ticker: N/A
Reported as of: 13 Dec 2022
Net transaction value: -$2,530,500
SEC form: 4
Accepted by SEC: 15 Dec 2022, 15:10:24 UTC
Prior SEC filing: 06 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ David Schulte, Senior Vice President and Managing Director of MCKESSON VENTURES, LLC

Key filing fact

McKesson Ventures, LLC filed Form 4 for Augmedix, Inc. on 15 Dec 2022.

Key facts

This page summarizes McKesson Ventures, LLC's Form 4 filing for Augmedix, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Dec 2022, 15:10.

Change

Previous filing in this sequence was filed on 06 Oct 2022.
Current net transaction value: -$2,530,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AUGX transaction

Common Stock

Sale

Transaction value: $2,530,500
Shares: -2,410,000
Change %: -61%
Price: $1.05^*
Shares after: 1,572,432
Date: 13 Dec 2022
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

McKesson Ventures, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.